Ultrasonographic Evaluation of the Sciatic Nerve in Patients With Piriformis Syndrome
Launched by ISTANBUL UNIVERSITY - CERRAHPASA · Jan 14, 2025
Trial Information
Current as of July 09, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a condition called Piriformis Syndrome (PS), which occurs when the sciatic nerve is compressed or irritated by the piriformis muscle in the buttocks. This can cause pain that radiates down the leg, often affecting middle-aged individuals. The researchers want to use ultrasound imaging to compare the thickness of the piriformis muscle and the sciatic nerve in patients with this syndrome. By doing so, they hope to learn more about whether the pain comes mainly from muscle issues or nerve compression.
To participate in the trial, individuals must be between 18 and 70 years old and have hip or leg pain on one side, along with specific signs that indicate Piriformis Syndrome. However, those with certain conditions, like a history of surgery in the area, serious health issues, or obesity, will not be eligible. Participants can expect to undergo ultrasound tests and possibly receive diagnostic injections to help identify their condition more clearly. This research could lead to better understanding and treatment options for people suffering from this painful syndrome.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients aged between 18 and 70 years with unilateral hip and/or leg pain
- • Positive FAIR (flexion, adduction, internal rotation) test
- • Tenderness to palpation in the Piriformis muscle
- Exclusion Criteria:
- • Patients with a history of previous surgery involving the lumbar and/or hip region
- • A history of malignancy or infection in the pelvic region
- • Body mass index (BMI) Greater than 30 kg/m2
- • Psychiatric diseases
- • Vascular disease
- • Uncontrolled diabetes, hypertension or heart failure,
- • Disc pathologies that may cause radiculopathy
- • History of rheumatic disease.
About Istanbul University Cerrahpasa
Istanbul University - Cerrahpasa is a prestigious academic institution renowned for its commitment to advancing medical research and education. With a focus on innovative clinical trials, the university harnesses cutting-edge methodologies to address pressing health challenges. Its collaborative environment fosters interdisciplinary research, enabling the development of effective therapeutic strategies and enhancing patient care. The institution's dedication to ethical standards and patient safety underscores its reputation as a leader in clinical research within the region and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Istanbul, , Turkey
Patients applied
Trial Officials
Selim Sezikli
Principal Investigator
Istanbul Physical Medicine Rehabilitation Training and Research Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported